In the second week of oral…
In the second week of oral Wegovy’s launch, which ended [...]
In the second week of oral Wegovy’s launch, which ended [...]
Plotting a challenge to Regeneron’s blockbuster Eylea, Ocular Therapeutix has [...]
Astellas CEO said he doesn’t want to make acquisitions simply [...]
As Lindsey Vonn’s comeback run heads toward a peak with [...]
The project, which involves Merck, SK Biosciences, Hilleman Laboratories and [...]
The company announced a phase 3 win in the rare [...]
While much of the biopharma industry has spent the past [...]
As the U.S. government intensifies efforts to acquire Greenland, President [...]
Following an FDA marketing suspension, Valneva has decided to voluntarily [...]
Just days after AbbVie unveiled a major new oncology play [...]